Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Najjar

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogsAmer M Najjar, Ryuichi Nishii, David S Maxwell, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 17, 2015
High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletionCaixia Li, Silas A Culver, Syed Quadri, et al.
Archives of Gerontology and Geriatrics|October 20, 2009
Serial position effect in a free recall task: differences between probable dementia of Alzheimer type (PDAT), vascular (VaD) and mixed etiology dementia (MED)G Orru, S Sampietro, S Catanzaro, et al.
Metabolism and Target Organ Damage|December 6, 2024
Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1Basel G Aldroubi, John A Najjar, Tya S Youssef, et al.
International Journal of Pharmaceutics|February 27, 2023
Cosmeceutical formulations of pro-vitamin E phosphate: In-vitro release testing and dermal penetration into excised human skinMais M Saleh, Raghad M Abuhamdan, Walhan Alshaer, et al.
Life (Basel, Switzerland)|March 27, 2025
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector MoleculesMartin Tobi, Daniel Ezekwudo, Benita McVicker, et al.
Hepatic Medicine : Evidence and Research|September 28, 2011
Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitisSumona Ghosh, Meenakshi Kaw, Payal R Patel, et al.
Mechanisms of Ageing and Development|November 6, 2025
Diminished CEACAM1 level plays a critical role in age-related hepatic fibrosisSobia Zaidi, Suman Asalla, Raziyeh Abdolahipour, et al.
Annals of Clinical and Translational Neurology|June 15, 2026
Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple SclerosisNabil K El Ayoubi, Sola Al Ghazal, Salem Hannoun, et al.
Physiological Genomics|January 4, 2008
Aerobic capacity-dependent differences in cardiac gene expressionAnja Bye, Mette Langaas, Morten A Høydal, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogsAmer M Najjar, Ryuichi Nishii, David S Maxwell, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 17, 2015
High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletionCaixia Li, Silas A Culver, Syed Quadri, et al.
Archives of Gerontology and Geriatrics|October 20, 2009
Serial position effect in a free recall task: differences between probable dementia of Alzheimer type (PDAT), vascular (VaD) and mixed etiology dementia (MED)G Orru, S Sampietro, S Catanzaro, et al.
Metabolism and Target Organ Damage|December 6, 2024
Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1Basel G Aldroubi, John A Najjar, Tya S Youssef, et al.
International Journal of Pharmaceutics|February 27, 2023
Cosmeceutical formulations of pro-vitamin E phosphate: In-vitro release testing and dermal penetration into excised human skinMais M Saleh, Raghad M Abuhamdan, Walhan Alshaer, et al.
Life (Basel, Switzerland)|March 27, 2025
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector MoleculesMartin Tobi, Daniel Ezekwudo, Benita McVicker, et al.
Hepatic Medicine : Evidence and Research|September 28, 2011
Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitisSumona Ghosh, Meenakshi Kaw, Payal R Patel, et al.
Mechanisms of Ageing and Development|November 6, 2025
Diminished CEACAM1 level plays a critical role in age-related hepatic fibrosisSobia Zaidi, Suman Asalla, Raziyeh Abdolahipour, et al.
Annals of Clinical and Translational Neurology|June 15, 2026
Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple SclerosisNabil K El Ayoubi, Sola Al Ghazal, Salem Hannoun, et al.
Physiological Genomics|January 4, 2008
Aerobic capacity-dependent differences in cardiac gene expressionAnja Bye, Mette Langaas, Morten A Høydal, et al.
Pageof 19